# Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats.

> PubMed lists PMID 40646278 in Journal of neural transmission (Vienna, Austria : 1996) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-07-12 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40646278-liraglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40646278-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-40646278-liraglutide-v1.json
- Content SHA-256: `604c34c68606e969044927fa402af8b361981b22949edf587fa1f966b12536bc`

## Claims and source pins

### Headline

Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats. ([`pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce`](#source-pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce))

### Summary

PubMed lists PMID 40646278 in Journal of neural transmission (Vienna, Austria : 1996) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-07-12 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce`](#source-pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce))

### Paragraph 1

PubMed lists PMID 40646278 in Journal of neural transmission (Vienna, Austria : 1996) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-07-12 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce`](#source-pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce`](#source-pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce))

## Sources

<a id="source-pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce"></a>
- **Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats. · retained source version 1:2026-06-04:current:d7efec2d77ce1a57e4ca9be2bccc87105908333fff9733dda63847a8d0c6ffc0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40646278/) (`pubmed-observation-pmid-40646278-2026-06-04-d7efec2d77ce`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-40646278-liraglutide-v1.json SHA-256: 604c34c68606e969044927fa402af8b361981b22949edf587fa1f966b12536bc.